121 related articles for article (PubMed ID: 10096794)
1. Towards a World Health Organization (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies.
Lernmark A; Kolb H; Mire-Sluis T
Diabetologia; 1999 Mar; 42(3):381-2. PubMed ID: 10096794
[No Abstract] [Full Text] [Related]
2. The World Health Organization International Collaborative Study for islet cell antibodies.
Mire-Sluis AR; Gaines Das R; Lernmark A
Diabetologia; 2000 Oct; 43(10):1282-92. PubMed ID: 11079747
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
Zerbini G; Bazzigaluppi E; Mangili R; Bosi E; Bonifacio E
Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
[No Abstract] [Full Text] [Related]
4. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
[TBL] [Abstract][Full Text] [Related]
5. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
[No Abstract] [Full Text] [Related]
6. 3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD
Amoroso M; Achenbach P; Powell M; Coles R; Chlebowska M; Carr L; Furmaniak J; Scholz M; Bonifacio E; Ziegler AG; Rees Smith B
Clin Chim Acta; 2016 Nov; 462():60-64. PubMed ID: 27570064
[TBL] [Abstract][Full Text] [Related]
7. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
Bonifacio E; Bingley PJ
Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
[No Abstract] [Full Text] [Related]
8. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
[TBL] [Abstract][Full Text] [Related]
9. Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies.
Costa A; Conget I; Casamitjana R
Diabetes Care; 2000 Jun; 23(6):874. PubMed ID: 10841023
[No Abstract] [Full Text] [Related]
10. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
11. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
13. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
[TBL] [Abstract][Full Text] [Related]
14. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
[TBL] [Abstract][Full Text] [Related]
15. The development of a World Health Organisation international standard for islet cell antibodies: the aims and design of an international collaborative study.
Mire-Sluis AR; Das RG; Lernmark A
Diabetes Metab Res Rev; 1999; 15(1):72-7. PubMed ID: 10398550
[TBL] [Abstract][Full Text] [Related]
16. GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy.
Petersen JS; Dyrberg T; Damm P; Kühl C; Mølsted-Pedersen L; Buschard K
Diabetologia; 1996 Nov; 39(11):1329-33. PubMed ID: 8933000
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.
Hagopian WA; Karlsen AE; Gottsäter A; Landin-Olsson M; Grubin CE; Sundkvist G; Petersen JS; Boel E; Dyrberg T; Lernmark A
J Clin Invest; 1993 Jan; 91(1):368-74. PubMed ID: 8423232
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
Zanone MM; Petersen JS; Peakman M; Mathias CJ; Watkins PJ; Dyrberg T; Vergani D
Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615
[TBL] [Abstract][Full Text] [Related]
19. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
